This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Amsterdam Molecular Therapeutics Announces Completion Of Disposal Of Its Operations To UniQure B.V. And Its Dissolution Becoming Effective

AMSTERDAM, April 5, 2012 /PRNewswire/ --

Amsterdam Molecular Therapeutics (AMT) Holding N.V. in liquidation ( in liquidatie) (Euronext: AMT), announces that following the approval of the corporate restructuring and financing transaction by the Extraordinary General Meeting (" EGM") of shareholders that was held on 30 March 2012, completion of the disposal of AMT's entire business and operations to uniQure B.V. has taken place on 5 April 2012. Immediately following the completion of the disposal and consequently as per 5 April 2012, the dissolution of the company as resolved by the EGM has become effective, with Mr. Jörn Aldag and Mr. Piers Morgan being the liquidators that shall liquidate the company's dissolved property.

As consideration for the disposed business and operation, AMT received 31,101,065 depositary receipts ( certificaten van aandelen) for (class B) ordinary shares in uniQure B.V. (" uniQure DRs"). Because AMT's dissolved property consists of the uniQure DRs without it having any known financial liabilities, and the financial condition is expected to justify the same, the liquidators of AMT intend to make an advance liquidation distribution (the " Advance Distribution") to the AMT shareholders by distributing and allocating to each such shareholder one uniQure DR for each AMT share held on the Distribution Record Date.  The Distribution Record Date is expected to be 23 April 2012 and the date on which the Advance Distribution of the uniQure DRs is expected to take place is 26 April 2012.

The Advance Distribution of the uniQure DRs to the AMT shareholders will be settled through the book entry system operated by Euroclear Netherlands, and will result in one uniQure DR being credited in the securities account of each AMT shareholder for each AMT share held on the Distribution Record Date. Consequently, to receive uniQure DRs, a person must hold AMT shares on the Distribution Record Date. To hold AMT shares on the Distribution Record Date, a shareholder must have bought such shares before the Ex Date, which shall be the second business day prior to the Distribution Record Date. Conversely, shareholders that do not want to receive uniQure DRs, must sell their AMT shares before the Ex Date. Shareholders having questions or requiring additional information on this settlement though Euroclear Netherlands are recommended to contact their bank or intermediary or other adviser.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $94.99 0.00%
FB $99.54 0.00%
GOOG $678.11 0.00%
TSLA $148.25 0.00%
YHOO $26.82 0.00%


Chart of I:DJI
DOW 16,014.38 -12.67 -0.08%
S&P 500 1,852.21 -1.23 -0.07%
NASDAQ 4,268.7630 -14.99 -0.35%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs